Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | MGAM | O43451 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | SI | P14410 | 1/20 | 0.39 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.37 |
| ▸ | KIF11 | P52732 | 1/20 | 0.36 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16775785 | 1.00 | ALDH1A1 (0.40) | ALDH1A1TDP1MGAMGAASI | |
| SCHEMBL16775768 | 1.00 | ALDH1A1 (0.40) | ALDH1A1TDP1MGAMGAASI | |
| Hydrochloric Acid SCHEMBL3394169 | 0.98 | ALDH1A1 (0.41) | ALDH1A1TDP1MGAMGAASI | |
| SCHEMBL29763322 | 0.84 | MME (0.34) | ALDH1A1KIF11GRIK1SLC1A1 | |
| SCHEMBL8894673 | 0.82 | SMN1; SMN2 (0.42) | ALDH1A1SMN1; SMN2KIF11CA1CA2 | |
| SCHEMBL25006833 | 0.82 | ALDH1A1 (0.36) | ALDH1A1SMN1; SMN2KIF11GRIK1CA1 | |
| SCHEMBL10458343 | 0.82 | ALDH1A1 (0.36) | ALDH1A1SMN1; SMN2KIF11GRIK1CA1 | |
| SCHEMBL30765423 | 0.81 | GRIK1 (0.32) | ALDH1A1MGAMGAASIMGAM2 | |
| Methyl Aminolevulinate SCHEMBL15345257 | 0.81 | LMNA (0.61) | ALDH1A1MGAMGAASIMGAM2 | |
| SCHEMBL6259101 | 0.81 | KMT2A (0.37) | SMN1; SMN2KIF11KMT2ASLC1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3657 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4719373-A1 | PHOTODYNAMIC THERAPY COMBINATIONS FOR IMPROVEMENT OF ACTINIC KERATOSIS, ACNE AND BASAL CELL CARCINOMA | Alexandroff, Anton (GB) | 2026-04-08 | — | — | EP | claimed |
| US-20260085061-A1 | PHTHALAZINE DERIVATIVES AS PYRUVATE KINASE MODULATORS | SITRYX THERAPEUTICS LIMITED (GB) | 2026-03-26 | — | — | US | claimed |
| US-12433477-B2 | Contrast enhancement for medical imaging | STRYKER CORPORATION (US) | 2025-10-07 | — | — | US | claimed |
| EP-4612132-A1 | PHTHALAZINE DERIVATIVES AS PYRUVATE KINASE MODULATORS | Sitryx Therapeutics Limited (GB) | 2025-09-10 | — | — | EP | claimed |
| US-12364682-B2 | Use of tegaserod in preparation of anti-tumor drug | QINGDAO HAIJI BIOMEDICINE CO., LTD. (CN) | 2025-07-22 | — | — | US | claimed |
| CN-120166987-A | Phthalazine derivatives as pyruvate kinase modulators | 西特瑞治疗有限公司 | 2025-06-17 | — | — | CN | claimed |
| WO-2025121735-A1 | PHARMACEUTICAL COMPOSITION COMPRISING UPCONVERSION NANOPARTICLES FOR PREVENTING OR TREATING CANCER | 부산대학교 산학협력단 | 2025-06-12 | — | — | WO | claimed |
| US-20250177423-A1 | PHOTORESPONSIVE PEPTIDE DELIVERY SYSTEM AND METHOD OF USING THE SAME | THE UNIVERSITY OF HONG KONG (CN) | 2025-06-05 | — | — | US | claimed |
| WO-2025111482-A1 | COMPLEXING AGENT SALT FORMULATIONS OF PHARMACEUTICAL COMPOUNDS AT LOW STOICHIOMETRIC RATIOS | BEXSON BIOMEDICAL, INC. (US) | 2025-05-30 | — | — | WO | claimed |
| US-12280050-B2 | Therapeutic compositions, combinations, and methods of use | THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL (GB) | 2025-04-22 | — | — | US | claimed |
| US-20080125485-A1 | 2-(acetyloxy)-5-hydroxybenzenesulfonic acid, or 5-(acetyloxy)-2-hydroxybenzene-sulfonic acid, or 2,5-bis(acetyloxy)benzenesulfonic acid; skin disorders like skin wrinkles, actinic keratosis, skin pigmentation and hyperpigmentation, hirsutism and hypertricosis, obesity due to adipogenesis | ACTION MEDICINES (ES) | 2008-05-29 | — | — | US | claimed |
| US-20080114060-A1 | 2-(acetyloxy)-5-hydroxybenzenesulfonic acid, or 5-(acetyloxy)-2-hydroxybenzene-sulfonic acid, or 2,5-bis(acetyloxy)benzenesulfonic acid, or sultosilic acid for example; combination therapy with other drugs or photodynamic therapy | ACTION MEDICINES (ES) | 2008-05-15 | — | — | US | claimed |
| WO-2008048190-A1 | UPCONVERSION FLUORESCENT NANO-STRUCTURED MATERIAL AND USES THEREOF | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2008-04-24 | — | — | WO | claimed |
| WO-2008020027-A2 | 2,5-DIHYDROXYBENZENE COMPOUNDS FOR THE TREATMENT OF SKIN CANCER | ACTION MEDICINES, S.L. (ES) | 2008-02-21 | — | — | WO | claimed |
| WO-2008020025-A1 | USE OF 2,5-DIHYDROXYBENZENE DERIVATIVES FOR TREATING ACTINIC KERATOSIS | ACTION MEDICINES, S.L. (ES) | 2008-02-21 | — | — | WO | claimed |
| WO-2007061529-A1 | LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY | SCIDOSE LLC. (US) | 2007-05-31 | — | — | WO | claimed |
| US-20070116729-A1 | Lyophilization process and products obtained thereby | SCIDOSE LLC | 2007-05-24 | — | — | US | claimed |
| WO-2004024144-A9 | METHOD OF TREATING SKIN DISORDERS | CANDELA CORP (US) | 2004-06-17 | — | — | WO | claimed |
| WO-2004024144-A1 | METHOD OF TREATING SKIN DISORDERS | CANDELA CORPORATION (US) | 2004-03-25 | — | — | WO | claimed |
| US-20040048842-A1 | Method of treating skin disorders | CANDELA CORPORATION | 2004-03-11 | — | — | US | claimed |